Acute chest syndrome in adult patients with sickle cell disease: The relationship with the time to onset after hospital admission

Author:

Cheminet Geoffrey12ORCID,Brunetti Antoine3,Khimoud Djamal2,Ranque Brigitte124,Michon Adrien2,Flamarion Edouard2,Pouchot Jacques12,Jannot Anne‐Sophie135,Arlet Jean‐Benoît126

Affiliation:

1. Université Paris Cité Paris France

2. AP‐HP, Hôpital Européen Georges Pompidou, DMU ENDROMED, Service de Médecine Interne Centre National de Référence de la drépanocytose et autres maladies rares des globules rouges Paris France

3. Service d'Informatique, de biostatistique et santé publique AP‐HP, Hôpital Européen Georges Pompidou Paris France

4. Hôpital Européen Georges Pompidou, AP‐HP, Université Paris Cité, INSERM U970 Equipe 4 “Epidémiologie cardiovasculaire et mort subite” Paris Centre de Recherche Cardiovasculaire Paris France

5. HEKA Centre de Recherche des Cordeliers, INSERM, INRIA Paris France

6. Laboratoire d'excellence GR‐Ex, Hôpital Necker, AP‐HP Université Paris Cité, INSERM U1163, CNRS 8254, institut IMAGINE Paris France

Abstract

SummaryData on acute chest syndrome (ACS) in adult sickle cell disease patients are scarce. In this study, we describe 105 consecutive ACS episodes in 81 adult patients during a 32‐month period and compare the characteristics as a function of the time to onset after hospital admission for a vaso‐occlusive crisis (VOC), that is early‐onset episodes (time to onset ≤24 h, 42%) versus secondary episodes (>24 h, 58%; median [interquartile range] time to onset: 2 [2–3] days). The median age was 27 [22–34] years, 89% of the patients had an S/S or S/β0‐thalassaemia genotype; 81% of the patients had a history of ACS (median: 3 [2–5] per patient), only 61% were taking a disease‐modifying treatment at the time of the ACS. Fever and chest pain were noted in respectively 54% and 73% of the episodes. Crackles (64%) and bronchial breathing (32%) were the main abnormal auscultatory findings. A positive microbiological test was found for 20% of episodes. Fifty percent of the episodes required a blood transfusion; ICU transfer and mortality rates were respectively 29% and 1%. Secondary and early‐onset forms of ACS did not differ significantly. Disease‐modifying treatments should be revaluated after each ACS episode because the recurrence rate is high.

Publisher

Wiley

Subject

Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3